Michael McLaughlin, DO
Interventional Pain Medicine · Moore, OKNPI 1376779231
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $4,162 of the $6,877 with a category attached, or 60.5%. 19 manufacturers reported payments, led by Abbott at 49.9% of the total. Reporting peaked in 2019 at $2,890 and has fallen 69.2% since, to $890 in 2025.
Across 267 payments — averaging $25.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Abbott$3K
- Medtronic$2K
- Boston Scientific$485
- Biohaven Pharmaceutical Holding Company Ltd.$75
- SPR Therapeutics, Inc$52
- Pfizer$50
- plus $349 from 13 others
What the payments were for
- Speaking & faculty fees$2,31034%
- Travel & lodging$4056%
- Food & beverage$4,16261%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Abbott | 225 | $3,431 |
| Medtronic(2 entities) | 5 | $2,435 |
| Boston Scientific | 4 | $485 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $75 |
| SPR Therapeutics, Inc | 3 | $52 |
| Pfizer | 3 | $50 |
| Novo Nordisk | 3 | $48 |
| Amgen | 3 | $48 |
| Dexcom, Inc. | 3 | $48 |
| Nevro Corp. | 3 | $43 |
| Idorsia Pharmaceuticals US Inc | 2 | $30 |
| Otsuka America Pharmaceutical, Inc. | 1 | $25 |
| Boehringer Ingelheim | 1 | $19 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $18 |
| Vertex | 1 | $17 |
| Arbor Pharmaceuticals, Inc. | 1 | $15 |
| Azurity Pharmaceuticals, Inc. | 1 | $15 |
| AstraZeneca | 1 | $13 |
| Nestle Healthcare Nutrition Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- ADAPTIVESTIM$2,310
- GENERAL - THERAPIES$405
- PROCLAIM$393
- Proclaim Family of SCS IPGs$303
How this compares
$6,877 in reported general payments places this provider in the 75th percentile of 27 interventional pain medicine providers in Oklahoma.
See all interventional pain medicine providers in Oklahoma →
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Buprenorphine | 97 | $28,261 |
| Gabapentin | 641 | $12,259 |
| BelbucaBuprenorphine Hcl | 17 | $9,734 |
| Pregabalin | 318 | $6,869 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 214 | $5,458 |
| Celecoxib | 141 | $4,952 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 120 | $3,136 |
| Duloxetine Hcl | 128 | $2,794 |
| Buprenorphine Hcl | 67 | $2,032 |
| Cyclobenzaprine Hcl | 116 | $1,959 |
| Orphenadrine Citrate ErOrphenadrine Citrate | 29 | $1,886 |
| Methocarbamol | 90 | $1,667 |
| Meloxicam | 295 | $1,651 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 33 | $1,477 |
| Tramadol Hcl ErTramadol Hcl | 22 | $1,416 |
Paid to pharmacies, not to this prescriber.
Other interventional pain medicine in Moore
- Brandon ValantineOklahoma City$9K
- Amer NouhEdmond$8K
- Muhammad MaqboolTulsa$8K
- Justin PorterOklahoma City$8K
- Samuel KorbeTulsa$7K
- Joshua WoolardEdmond$7K
- Steve RandallMidwest City$6K
- Blake ChristensenOklahoma City$6K
- Shawn EllisOklahoma City$6K
- Nathan OverbeyOklahoma City$5K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.